ERBB2 and breast carcinoma: Interestingly, slight ERBB2 expression was found in the luminal subtype, and the results were compatible with the previous studies on clinical trials that ERBB2-targeted therapy demonstrated better survival in patients with HER2-low breast cancer [36].